Skip to main content
. 2017 Mar 21;17:206. doi: 10.1186/s12885-017-3191-y

Fig. 3.

Fig. 3

The correlation between tumor marker expression in breast tumors and ovarian metastases for individual patients. Upper panel (a) shows invasive ductal breast cancer and lower panel (b) represents invasive lobular breast cancer. For each patient, the percentage of positive tumor cells in primary and locally recurrent breast tumors (if applicable) was set against the percentage of positive tumor cells in their corresponding ovarian metastases. EMA, epithelial membrane antigen; Her2/neu, human epidermal growth receptor type 2; EpCAM, epithelial cell adhesion molecule